Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a Porcine Model - Concepedia

Concepedia

Publication | Open Access

Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a Porcine Model

DOI Full Paper Access

93

Citations

48

References

2016

Year

Charlotte Bernigaud, Fang Fang, Katja Fischer, Anne Lespine, Serge Aho, Dominique Dreau, Andrew B. Kelly, Jean‐François Sutra, Francis Moreau, Thomas Lilin,

PLoS neglected tropical diseases

Abstract

Our data demonstrate that oral single-dose MOX was more effective than two consecutive IVM-doses, supporting MOX as potential therapeutic approach for scabies.

References

	Year	Citations

Page 1